BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 32555118)

  • 21. THE NITROSAMINE CONTAMINATION IN BETA BLOCKERS (BISOPROLOL/METOPROLOL), ACE INHIBITORS (LISINOPRIL/PERINDOPRIL), THIAZIDES DIURETICS (HCT), CALCIUM CHANNEL BLOCKERS (AMLODIPINE/FELODIPINE), SARTANS (CANDESARTAN) AND ТHE SUBSEQUENT SKIN CANCER DEVELOPMENT AND PROGRESSION: APOCALYPSE NOW.
    Tchernev G
    Georgian Med News; 2023 Apr; (337):138-145. PubMed ID: 37354687
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trough/peak ratios of once daily angiotensin converting enzyme inhibitors and calcium antagonists.
    Zannad F; Matzinger A; Larché J
    Am J Hypertens; 1996 Jul; 9(7):633-43. PubMed ID: 8806975
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Eptinezumab (Vyepti) for migraine prevention.
    Med Lett Drugs Ther; 2020 Jun; 62(1599):85-87. PubMed ID: 32555116
    [No Abstract]   [Full Text] [Related]  

  • 24. Antihypertensive drug prescription trends at the primary health care centres in Bahrain.
    Jassim al Khaja KA; Sequeira RP; Wahab AW; Mathur VS
    Pharmacoepidemiol Drug Saf; 2001 May; 10(3):219-27. PubMed ID: 11501335
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Atenolol. A reappraisal of its pharmacological properties and therapeutic use in cardiovascular disorders.
    Wadworth AN; Murdoch D; Brogden RN
    Drugs; 1991 Sep; 42(3):468-510. PubMed ID: 1720383
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preventing, detecting and managing adverse reactions of antihypertensive agents in the ambulant patient with essential hypertension.
    Riddiough MA
    Am J Hosp Pharm; 1977 May; 34(5):465-79. PubMed ID: 326040
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term hemodynamic effects at rest and during exercise of newer antihypertensive agents and salt restriction in essential hypertension: review of epanolol, doxazosin, amlodipine, felodipine, diltiazem, lisinopril, dilevalol, carvedilol, and ketanserin.
    Omvik P; Lund-Johansen P
    Cardiovasc Drugs Ther; 1993 Apr; 7(2):193-206. PubMed ID: 8395198
    [TBL] [Abstract][Full Text] [Related]  

  • 28. What can we do to make antihypertensive medications taste better for children?
    Ferrarini A; Bianchetti AA; Fossali EF; Faré PB; Simonetti GD; Lava SA; Bianchetti MG
    Int J Pharm; 2013 Nov; 457(1):333-6. PubMed ID: 23906666
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Results of ACES (Antihypertensive Combinations' Long Term Efficacy Comparing Study): Analysis of Metabolic Effects of Antihypertensive Combination Therapies.
    Nádházi Z; Dézsi CA
    Clin Drug Investig; 2016 Oct; 36(10):819-27. PubMed ID: 27405983
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fosinopril: a reappraisal of its pharmacology and therapeutic efficacy in essential hypertension.
    Wagstaff AJ; Davis R; McTavish D
    Drugs; 1996 May; 51(5):777-91. PubMed ID: 8861547
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of different fixed antihypertensive combination drugs: a double-blind, placebo-controlled parallel group study.
    de Leeuw PW; Notter T; Zilles P
    J Hypertens; 1997 Jan; 15(1):87-91. PubMed ID: 9050975
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nebivolol: a third-generation beta-blocker for hypertension.
    Cheng JW
    Clin Ther; 2009 Mar; 31(3):447-62. PubMed ID: 19393838
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drugs used in the treatment of hypertension.
    Finnerty FA
    Mod Concepts Cardiovasc Dis; 1973 Jul; 42(7):33-6. PubMed ID: 4786758
    [No Abstract]   [Full Text] [Related]  

  • 34. Pharmacologic treatment of chronic pediatric hypertension.
    Robinson RF; Nahata MC; Batisky DL; Mahan JD
    Paediatr Drugs; 2005; 7(1):27-40. PubMed ID: 15777109
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Additional antihypertensive effect of drugs in hypertensive subjects uncontrolled on diltiazem monotherapy: a randomized controlled trial using office and home blood pressure monitoring.
    Karotsis AK; Symeonidis A; Mastorantonakis SE; Stergiou GS;
    Clin Exp Hypertens; 2006 Oct; 28(7):655-62. PubMed ID: 17060064
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trandolapril: a newer angiotensin-converting enzyme inhibitor.
    Guay DR
    Clin Ther; 2003 Mar; 25(3):713-75. PubMed ID: 12852701
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum lipoproteins during treatment with antihypertensive drugs.
    Weidmann P; Ferrier C; Saxenhofer H; Uehlinger DE; Trost BN
    Drugs; 1988; 35 Suppl 6():118-34. PubMed ID: 3042351
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in the Preventative Treatment of Episodic Migraine in Adults.
    Dorosch T; Ganzer CA; Lin M; Seifan A
    Curr Pain Headache Rep; 2019 Sep; 23(11):85. PubMed ID: 31515634
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Administration-time differences in effects of hypertension medications on ambulatory blood pressure regulation.
    Hermida RC; Ayala DE; Fernández JR; Mojón A; Smolensky MH; Fabbian F; Portaluppi F
    Chronobiol Int; 2013 Mar; 30(1-2):280-314. PubMed ID: 23077971
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.